Moneycontrol
HomeNewsBusinessEconomyFitch Ratings cuts China’s 2022 growth forecast amid uptick in COVID-19 cases
Trending Topics

Fitch Ratings cuts China’s 2022 growth forecast amid uptick in COVID-19 cases

The ratings agency has; however, revised its 2023 growth forecast for China from 5.1 percent to 5.2 percent based on the assumption that Beijing would gradually phase out its ‘dynamic zero-Covid’ policy over the next year.

May 03, 2022 / 15:48 IST
Story continues below Advertisement
Representative image

China’s GDP growth forecast for 2022 has been cut by Fitch Ratings from 4.8% to 4.3% in the backdrop of rising coronavirus cases in the country, which led to the adoption of policies that restricted mobility in the important commercial hub of Shanghai aside from broader restrictions across the nation.

The ratings agency has; however, revised its 2023 growth forecast for China from 5.1 percent to 5.2 percent based on the assumption that Beijing would gradually phase out its ‘dynamic zero-Covid’ policy over the next year.

Story continues below Advertisement

They explained that their forecast is subject to downside risk if containment measures fail to bring new outbreaks under control quickly or if the easing of current restrictions is delayed, and based on the assumption that Beijing would adhere to the ‘dynamic zero’ strictly until 2023.

"Spillover to economic activity from Covid-19 pandemic-related disruption became apparent in March, with retail sales falling by 3.5%, the first YoY decline since mid-2020. Selected sub-components contracted even more severely; for example, catering was down by 15.6% YoY. Other areas of activity, including industrial production and fixed-asset investment, also slowed noticeably, as health and movement control disrupted domestic supply chains and labour availability," Fitch Ratings said in its statement.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show